Vaccine corona Covid-19
– – – – – – – – – –
Dow and S&P 500 hit new record highs after Moderna says vaccine is 94.5% effective
– – – – – – – – – –
US stocks rallied on Monday after Moderna said its experimental Covid-19 vaccine is highly effective.
– – – – – – – – – –
The Dow and the S&P 500 both notched new record highs.
The Dow (INDU) finished up 1.6%, or 471 points. The index closed only about 50 points below the 30,000 mark, a level it has not crossed in its history
– – – – – – – – – -.
The S&P 500 (SPX) closed up 1.2%, and the Nasdaq (COMP) ended 0.8% higher.
Shares of Moderna (MRNA) closed 9.6% higher after the company said in a statement that the first interim analysis of Phase 3 trial results showed its vaccine candidate was 94.5% effective against coronavirus
– – – – – – – – – -.
It’s another breakthrough in the fight against coronavirus that could eventually help the world’s biggest economies recover from deep recessions
– – – – – – – – – –
Last week, Pfizer (PFE) said that a vaccine it developed with German drugmaker BioNTech was more than 90% effective against Covid-19.
There are dozens more potential vaccines in development, and the promising test results from Moderna and Pfizer suggest that vaccines may be an effective way to fight the coronavirus. Both vaccines require two doses to be administered.
– – – – – – – – – –
US stocks rallied from the opening bell following Moderna’s early-morning announcement.
Neil Shearing, group chief economist at Capital Economics, wrote in a research note on Monday before the Moderna results were announced that vaccine breakthroughs show “there is finally light at the end of the tunnel
– – – – – – – – – –
“Forget the fact President Trump has refused to concede defeat in the US election, or that Europe and the US remain gripped by new waves of the virus, or that another key Brexit deadline has passed and a ‘no deal’ exit is edging closer. Markets are focused on the increasing likelihood of a vaccine breakthrough,” he wrote.
Yet there are reasons for investors to temper their enthusiasm. It will take months for the vaccines to be distributed, and the number of coronavirus cases in the United States is surging. Big economies in Europe such as France, Germany, and the United Kingdom have been locked down for a second time
– – – – – – – – – -.
Moderna said Monday that it expects to have roughly 20 million doses of its vaccine ready to ship in the United States by the end of this year. The company is on track to manufacture 500 million to 1 billion doses globally in 2021, it added.
Pfizer told CNN last week that it expects to have 50 million vaccine doses globally this year, and 1.3 billion in 2021.
– – – – – – – – – -.
疫苗電暈Covid-19
———-
摩登納表示疫苗有效率為94.5％後，道瓊斯指數和標準普爾500指數創下新高
—–
—–
在Moderna表示其實驗性Covid-19疫苗非常有效之後，美國股市週一上漲。
———-
道指和標普500指數均創下新高。
道瓊斯工業平均指數上漲1.6％，即471點。該指數收盤僅低於30,000點低約50點，該水平是其歷史上從未超過的水平
———–。
標準普爾500指數（SPX）收盤上漲1.2％，納斯達克（COMP）收盤上漲0.8％。
Moderna（MRNA）的股票上漲了9.6％。該公司在一份聲明中稱，對3期臨床試驗結果的首次中期分析顯示，其候選疫苗對冠狀病毒的有效率為94.5％。
—–
——。
這是抗擊冠狀病毒的又一突破，最終可能會幫助世界上最大的經濟體從嚴重的衰退中復蘇
———-
輝瑞公司（PFE）上週表示，它與德國製藥商BioNTech合作開發的一種疫苗對Covid-19的有效性超過90％。
尚有數十種潛在的疫苗正在開發中，而Moderna和Pfizer的有希望的測試結果表明，疫苗可能是對抗冠狀病毒的有效方法。兩種疫苗都需要注射兩次。
———-
在Moderna早盤宣布之後，美國股市從開盤價上漲。
Capital Economics集團首席經濟學家尼爾·希林（Neil Shearing）週一在一份研究報告中寫道，在Moderna結果宣布疫苗突破之前，“隧道盡頭終於輕了”
—-
——
“忘記特朗普總統拒絕承認在美國大選中失敗的事實，或者歐洲和美國仍然受到新一波病毒束縛的事實，或者英國退歐的另一個關鍵期限已經過去，’無協議’退出越來越臨近的事實。市場關注的是疫苗突破的可能性越來越大。”
然而，投資者仍有理由降低其熱情。分發疫苗需要幾個月的時間，而且在美國，冠狀病毒病例的數量正在激增。歐洲的大型經濟體，例如法國，德國和英國，已第二次被鎖定
———–。
Moderna週一表示，預計到今年年底將有大約2000萬劑疫苗準備在美國銷售。它補充說，該公司有望在2021年在全球生產5億至10億劑。
輝瑞公司上週告訴美國有線電視新聞網，它預計今年全球將接種5000萬劑疫苗，到2021年將達到13億劑。
———–。